|
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 904022
Online Users : 794
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/11051
|
Title: | Myeloid-derived macrophages and secreted HSP90alpha induce pancreatic ductal adenocarcinoma development |
Other Titles: | Myeloid-derived macrophages and secreted HSP90α induce pancreatic ductal adenocarcinoma development |
Authors: | Chen, CC;Chen, LL;Li, CP;Hsu, YT;Jiang, SS;Fan, CS;Chua, KV;Huang, SX;Shyr, YM;Chen, LT;Huang, TS |
Contributors: | National Institute of Cancer Research |
Abstract: | We detected a significant elevation of serum HSP90α levels in pancreatitis patients and even more in pancreatic ductal adenocarcinoma (PDAC) patients. However, there was no significant difference in the serum HSP90α levels between patients with early-stage and late-stage PDAC. To study whether elevation of serum HSP90α levels occurred early during PDAC development, we used LSL-KrasG12D/Pdx1-Cre transgenic mice as a studying model. Elevated serum HSP90α levels were detected before PDAC formation and an extracellular HSP90α (eHSP90α) inhibitor effectively prevented PDAC development. Both serum HSP90α level and pancreatic lesion were suppressed when the mice were administered a CD11b-antagonizing antibody, suggesting that CD11b+-myeloid cells were associated with eHSP90α levels and pancreatic carcinogenesis. Consistently, in CD11b-DTR-EGFP transgenic mouse model with CD11b+-myeloid cells depletion, serum HSP90α levels were suppressed and Panc-02 cell grafts failed to develop tumors. Macrophages and granulocytes are two common tissue-infiltrating CD11b+-myeloid cells. Duplex in situ hybridization assays suggested that macrophages were predominant HSP90α-expressing CD11b+-myeloid cells during PDAC development. Immunohistochemical and immunohistofluorescent staining results revealed that HSP90α-expressing cells included not only macrophages but also pancreatic ductal epithelial (PDE) cells. Cell culture studies also indicated that eHSP90α could be produced by macrophages and macrophage-stimulated PDE cells. Macrophages not only secreted significant amount of HSP90α, but also secreted interleukin-6 and interleukin-8 to induce a JAK2−STAT3 signaling axis in PDE cells, stimulating them to express and secrete HSP90α. eHSP90α further promoted cellular epithelial-mesenchymal transition, migration, and invasion in PDE cells. Besides myeloid cells, eHSP90α can be potentially taken as a target to suppress PDAC pathogenesis. |
Date: | 2018-02-01 |
Relation: | OncoImmunology. 2018 Feb 1;7(5):Article number e1424612. |
Link to: | http://dx.doi.org/10.1080/2162402X.2018.1424612 |
JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2162-402X&DestApp=IC2JCR |
Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000430504300019 |
Cited Times(Scopus): | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85041597406 |
Appears in Collections: | [黃智興] 期刊論文 [陳立宗] 期刊論文 [江士昇] 期刊論文
|
Files in This Item:
File |
Description |
Size | Format | |
SCP85041597406.pdf | | 4501Kb | Adobe PDF | 341 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|